This site is intended for health professionals only

At the heart of general practice since 1960

Read the latest issue online

A faulty production line

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Your comments will be sent to our moderator for review.

Report comment to moderator

Required fields.

Headline

GPs need a different approach to chronic pain

Comment

(1) This Gabapentinoid Crisis simply epitomised and exposed one fragility of the current NHS where patients needing more time of attention were shuffled from busy secondary care to busier primary care clinicians. Chronic pain , as we already discussed in another article, is more than upper respiratory tract infection, chest infection , gastroenteritis or even suspected cancers . Time consuming is inevitable if a proper review with some positive outcomes are desired . Yes , realistically , many are just staying on the drugs permanently. But the physical-mental-social medicine model always apply in chronic pain . Continuity of care supported by time , in my opinion , is essential. 10 minutes appointment is a joke in this context. (2) Alongside with tramadol , we do not seem to have learnt the lesson about all these new drugs into the market. NHS is a jewel on the crown and is particularly so in the eyes of pharmaceutical companies. Why were we so resistant to the Transatlantic trade and investment pact (TTIP)? I understand that they have good arguments about spending millions of pound in their researches and obviously need a positive reception but it does not mean a green light to exploit opportunitiscally the weaknesses of our beleaguered NHS( thanks to the good work of the government). (3) Do not want to point a finger solely on the academics but NICE needs to recognise their medico-legal representation and produces guidelines with more common senses , without fearing to 'disappoint' drug companies.Cockrane review in June this year is telling. Perhaps , under current crisis of GP workforce, the implication of being liberal in passing drugs for indications with unclear benefit , will simply increase our(GP) burden unnecessarily. (4) Without examining the current circumstances throughoutly , being strict or liberal still end up with mistakes, costly ones in this case . (5) Personally , I say yes to stop prescribing these drugs under current conditions we are under .

Posted date

04 Oct 2017

Posted time

12:39pm

required
required
required